Results 171 to 180 of about 6,082 (293)

Global Variability in Discoid Meniscus Management: A Comparative Study of Pediatric Research in Sports Medicine Asia‐Pacific and the Surgical Cohort Outcome Registry Experience Registry

open access: yesArthroscopy, Sports Medicine, and Rehabilitation, EarlyView.
Purpose To compare diagnostic emphasis and surgical management strategies for discoid meniscus (DM) between Asia‐Pacific surgeons participating in the Pediatric Research in Sports Medicine collaborative and North American surgeons within the Surgical Cohort Outcome Registry Experience registry.
Si Jian Hui   +6 more
wiley   +1 more source

Regional Differences in Publication Volume on Pediatric Sports Knee Conditions Between North America and the Asia‐Pacific Regions

open access: yesArthroscopy, Sports Medicine, and Rehabilitation, EarlyView.
Purpose To characterize and compare publication patterns for 5 major pediatric sports knee conditions—anterior cruciate ligament tears, discoid meniscus pathology, osteochondritis dissecans (OCD), patellar instability, and tibial eminence fractures—across North America and the Asia‐Pacific regions, examining regional research volume, condition‐specific
Bryan Chong   +3 more
wiley   +1 more source

Medical education in the first university of the world, the Jundishapur Academy. [PDF]

open access: yesJ Family Med Prim Care, 2022
Daneshfard B, Naseri M, Ghaffari F.
europepmc   +1 more source

Gender Equity in Rheumatology Research: Global Analysis of Authors

open access: yesArthritis &Rheumatology, EarlyView.
Objective To investigate gender representation of authors in rheumatology research over the last decade. Methods Using metadata from original and review articles published between 2015 and 2024 in SCImago top two quartile (Q1, Q2) rheumatology journals, author gender was classified using two public databases.
Michael Girdwood   +7 more
wiley   +1 more source

Efficacy and Safety of Nanoencapsulated Sirolimus Plus Pegadricase: Results From the Randomized, Placebo‐Controlled Phase 3 Trials

open access: yesArthritis &Rheumatology, EarlyView.
Objective DISSOLVE I and II examined the efficacy and safety of nanoencapsulated sirolimus (NAS) plus pegadricase (NASP) in patients with uncontrolled gout (UG). Methods In these double‐blind, placebo‐controlled Phase 3 trials of NASP, patients were randomized 1:1:1 to infusions of high‐dose (HD) or low‐dose (LD) NAS plus pegadricase (HD NASP, LD NASP,
Herbert S. B. Baraf   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy